RPS20P12

Across TCGA pan-cancer cohorts, RPS20P12 RNA is linked to patient survival in 23 of 34 cancer types, making it the most broadly survival-associated RPS20P12 data layer.

The strongest signal is observed in stomach adenocarcinoma (STAD), where higher RPS20P12 RNA is associated with worse disease-free survival. In most high-consensus cancer types, elevated RPS20P12 expression acts as an unfavorable survival marker, although some lineages such as BLCA and THYM show a favorable association.

STAD, ACC, and UCEC are the cancer types where RPS20P12 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
STAD	DFS	Tertile	III,IV	0.429	0.635	.004	74	view →
ACC	DFS	Median	IV	0.056	0.430	.001	69	view →
UCEC	OS	Tertile	All	0.552	0.766	<.001	62	view →
BLCA	OS	Median	All	0.741	0.425	<.001	50	view →
PAAD	OS	Tertile	All	0.298	0.515	.002	43	view →
UVM	OS	Median	III,IV	0.391	0.836	.009	34	view →
THYM	DFS	Tertile	II,III,IV	0.973	0.765	.005	31	view →
READ	OS	Tertile	II,III,IV	0.305	0.958	.004	26	view →
CESC	DFS	Quartile	II,III,IV	0.881	0.540	.001	26	view →
MESO	DFS	Median	II,III,IV	0.318	0.186	.019	21	view →
KIRC	DFS	Median	All	0.577	0.713	.009	18	view →
SARC	DFS	Median	All	0.533	0.671	.004	18	view →

Pink = unfavorable, green = favorable. Showing the 12 strongest of 23 lineages.

RPS20P12–STAD (DFS)

Open the STAD breakdown →